Cleared Traditional

K152028 - Volpara Imaging Software

K152028 is an FDA 510(k) clearance for Volpara Imaging Software, manufactured by Matakina Technologies Limited. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 96-day FDA review.

K152028 · Matakina Technologies Limited · Radiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2015
Decision
96d
Days
Class 2
Risk

K152028 is an FDA 510(k) clearance for the Volpara Imaging Software. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Matakina Technologies Limited (Wellington, NZ). The FDA issued a Cleared decision on October 26, 2015 after a review of 96 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

FDA 510(k) Submission Details - K152028

510(k) Number K152028 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2015
Decision Date October 26, 2015
Days to Decision 96 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
11d faster than avg
Panel avg: 107d · This submission: 96d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Sheila Pickering
SHEILA PICKERING

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 2241
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K152028.
HICAT Air
K152661 · Hicat GmbH · Nov 2015
UroNav (Version 2.0)
K153073 · Invivo Corporation · Nov 2015
Ziostation2
K151212 · Qi Imaging, LLC · Nov 2015
Visible Patient Suite
K151988 · Visible Patient, Sas · Oct 2015
DEXIS Webview
K151941 · Imaging Sciences International /Gendex/Dexis · Oct 2015
OrthoVis Web Portal
K151501 · Custom Orthopaedic Solutions, Inc. · Oct 2015